drugset / Trial / NCT07047651

Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.

NCT07047651

Phase 4 Active not recruiting 84 enrolled Dr. Stavroula Rakitzi
RandomizedParallel-groupSingle-blindTreatment

Summary

The effectiveness and efficacy of the combination of pharmacotherapy with the two new recovery-oriented programs, RECOVERYTRSGR for patients with treatment- resistant schizophrenia and RECOVERYTRSBDGR for patients with treatment- resistant bipolar disorder.

Timeline

Start
2025-06-04
Primary completion
2027-12-20
Completion
2027-12-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Aripiprazole Other / unclassified
Background Asenapine Other / unclassified
Background Citalopram Small molecule
Background Clonazepam Small molecule
Background Clozapine Other / unclassified
Background Lithium Unknown
Background Olanzapine Small molecule
Background Paliperidone Unknown
Background Risperidone Other / unclassified
Background Tavor Unknown
Background Valproic Acid Small molecule
Background Zuclopenthixol Unknown
Background quietiapine Unknown
Background stedon Unknown
Background zyprasidone Unknown